NIH team creates 3D structure of twinkle protein, sheds light on mitochondrial diseases
Researchers from the National Institutes of Health (NIH) have used cryo-electron microscopy and other techniques to create a 3D structure of the twinkle protein, the final piece of the human minimal mitochondrial replisome to be structurally characterized. Read More
First full map of immune system connections unlocks drug discovery opportunities
Researchers have created the first full map of immune system connections showing how immune cells communicate, pointing to ways to modulate the pathways to treat cancer and infectious diseases. Read More
Technology restores cell, organ function in pigs an hour after their deaths
Yale University scientists were able to restore blood circulation and other cellular functions in pigs a full hour after their deaths from cardiac arrest by using technology that delivers a specially designed cell-protective fluid to organs and tissues, according to a paper published August 3 in the journal Nature. Read More
Google’s DeepMind, Chan Zuckerberg Biohub hail separate AI-scientific breakthroughs
DeepMind and the European Molecular Biology Laboratory-European Bioinformatics Institute have used artificial intelligence (AI) to predict the 3D structures of nearly all cataloged proteins, while a team of Chan Zuckerberg Biohub scientists has developed a machine-learning method to quantitatively analyze and compare microscopy images of proteins with no prior knowledge. Read More
Video from AACC: Fluxergy's multimodal testing platform
Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction and serology tests, using a single instrument and software program. Read More
Video from AACC: PerkinElmer on diagnostics, acquisitions
Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec. Read More
Map of brain changes in Alzheimer’s reveals potential target cell for drug therapies
A National Institute of Aging-backed project has released large-scale cellular and molecular information taken from more than 1.2 million neurons and other brain cells. Read More
Video from AACC: Enzo BioChem CEO on COVID-19 test landscape
Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves. Read More
Video from AACC: AACC president on Theranos, VALID Act
Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago. Read More
Video from AACC: Cytovale immune-response test for sepsis
Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test. Read More
Conferences
Science Briefs
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
